76 more deaths investigated for possible link to Kobayashi Pharmaceutical's red yeast rice cholesterol tablets.

Japanese health supplement maker Kobayashi Pharmaceutical is investigating 76 more deaths possibly linked to its tablets containing red yeast rice, meant to lower cholesterol. This scandal deepens as the company initially probed five deaths potentially linked to the over-the-counter products after customers reported kidney problems. The ingredient red yeast rice, or "beni koji", has been used in food, alcoholic drinks and folk medicines for centuries around East Asia.

June 28, 2024
6 Articles

Further Reading